Cargando…

Comparison of proteomic and genomic analyses of vaccine cell lines shows men receiving prostate gvax immunotherapy develop increased humoral responses to common cell line proteins relative to mutated proteins

Detalles Bibliográficos
Autores principales:	Hulett, Tyler, Puri, Sachin, Curti, Brendan, Urba, Walter J, Fox, Bernard A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288656/ http://dx.doi.org/10.1186/2051-1426-2-S3-P49

Ejemplares similares

Evaluation of circulating tumor cell gene expression profiles before and following combination immunotherapy for advanced prostate cancer
por: Puri, Sachin, et al.
Publicado: (2014)

S48. Biomarker development for ipilimumab and prostate GVAX treatment
por: de Gruijl, T, et al.
Publicado: (2014)

Radiation and immunotherapy: Renewed allies in the war on cancer
por: Seung, Steven K., et al.
Publicado: (2012)

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy
por: Qin, L, et al.
Publicado: (2013)

Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
por: Nair, Nitya, et al.
Publicado: (2015)

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer
por: van de Ven, Rieneke, et al.
Publicado: (2013)

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
por: Lipson, Evan J, et al.
Publicado: (2015)

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab
por: Santegoets, Saskia JAM, et al.
Publicado: (2014)

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
por: van de Ven, Rieneke, et al.
Publicado: (2018)

Humoral immunostimulation. V. Selection of variant cell lines
Publicado: (1975)

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
por: Feng, Zipei, et al.
Publicado: (2015)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
por: Yarchoan, Mark, et al.
Publicado: (2019)

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
por: Page, David B., et al.
Publicado: (2016)

A humoral cytotoxic substance produced by a human killer cell line.
por: Karpas, A.
Publicado: (1977)

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab
por: Koguchi, Yoshinobu, et al.
Publicado: (2015)

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance
por: Couey, Marcus A., et al.
Publicado: (2019)

A human haemic cell line capable of cellular and humoral killing of normal and malignant cells.
por: Karpas, A.
Publicado: (1977)

Investigating citrullinated proteins in tumour cell lines
por: Jiang, Zhongmin, et al.
Publicado: (2013)

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
por: Mougdil, Tarsem, et al.
Publicado: (2015)

First line Immunotherapy for Non-Small Cell Lung Cancer
por: Nasser, Nicola J., et al.
Publicado: (2020)

Cancer cell lines show high heritability for motility but not generation time
por: Wass, Anastasia V., et al.
Publicado: (2020)

GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs
por: Guerrouahen, Bella S., et al.
Publicado: (2016)

High Throughput Chemical Screening Reveals Multiple Regulatory Proteins on FOXA1 in Breast Cancer Cell Lines
por: Wang, Shixiong, et al.
Publicado: (2018)

Industrial Production of Therapeutic Proteins: Cell Lines, Cell Culture, and Purification
por: Zhu, Marie M., et al.
Publicado: (2017)

Chemo-immunotherapy as first-line treatment for small-cell lung cancer
por: Farid, Saira, et al.
Publicado: (2020)

Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
por: Yang, Ya-Ting, et al.
Publicado: (2022)

DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
por: Hilton, Traci L, et al.
Publicado: (2013)

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy
por: Bigelow, Emma, et al.
Publicado: (2022)

Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
por: Belaroussi, Yaniss, et al.
Publicado: (2023)

Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies
por: Fox, Bernard A., et al.
Publicado: (2023)

Impact of fibroblast activation protein on osteosarcoma cell lines in vitro
por: DING, LIXIANG, et al.
Publicado: (2014)

Over-expression of secreted proteins from mammalian cell lines
por: Dalton, Annamarie C, et al.
Publicado: (2014)

Global Conservation of Protein Status between Cell Lines and Xenografts()
por: Biau, Julian, et al.
Publicado: (2016)

Multiplexed clonality verification of cell lines for protein biologic production
por: O’Brien, Sofie A., et al.
Publicado: (2020)

PIWI Proteins Play an Antiviral Role in Lepidopteran Cell Lines
por: Santos, Dulce, et al.
Publicado: (2022)

Depleting deubiquitinating enzymes promotes apoptosis in glioma cell line via RNA binding proteins SF2/ASF1
por: Vashistha, Vidhi, et al.
Publicado: (2020)

Analysis of Human Protein Replacement Stable Cell Lines Established using snoMEN-PR Vector
por: Ono, Motoharu, et al.
Publicado: (2013)

Novel cell engineering of the Unfolded Protein Response to achieve efficient therapeutic protein production cell line
por: Song, Michael C, et al.
Publicado: (2015)

First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function
por: Myers, Jamie S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ken9p7sahuo867esau61uh2kcq